ITMCTR2000003064RecruitingPhase 1
Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)
Affiliated Hospital of Changchun University of traditional Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational study
Eligibility Criteria
- Ages
- 18 to — (—)
- Sex
- All
Inclusion Criteria
- •1. Suspected, mild, normal and severe cases diagnosed in accordance with the diagnosis and treatment scheme for pneumonia of novel coronavirus infection (trial version 5);
- •2. Aged >= 18 years;
- •3. Patients who voluntarily participate in the study and sign informed consent.
Exclusion Criteria
- •(1) Known to be allergic to the ingredients contained in the research medication, or patients with allergies;
- •(2) Unwilling to cooperate with the information collector;
- •(3) Patients with mental illness, or cognitive impairment;
- •(4) Women who are breastfeeding or pregnant, or who have a positive urine pregnancy test, or who do not agree to contraception within 3 months of participating in the test;
- •(5) Other patients that the investigator considers unsuitable to participate in this study
Investigators
Similar Trials
Recruiting
Not Applicable
Clinical Study for Traditional Chinese Medicine in the Prevention and Treatment of Novel Coronavirus Pneumonia (COVID-19)ITMCTR2000002997The First Affiliated Hospital of Zhejiang University of Traditional Chinese Medicine
Not yet recruiting
Phase 1
A Randomized Controlled Clinical Study for Traditional Chinese Medicine to Improve the Clinical Benefit Rate of Advanced Esophageal CancerM8000/3Esophageal cancerITMCTR2000003504Henan Province Hospital of TCM
Recruiting
Phase 1
Clinical Study for Traditional Chinese Medicine Combined With Western Medicine in Treatment of Novel Coronavirus Pneumonia (COVID-19)ITMCTR2000003003Shanghai University of TCM
Recruiting
Phase 1
Clinical study of the traditional Chinese medicine wenyangtongluo formula combined with toripalimab plus apatinib and tegio as the third line for advanced gastric cancerStomach cancerITMCTR2200005508Department of Oncology of Integrated Traditional Chinese and Western Medicine, High-tech Campus, First Affiliated Hospital of Anhui
Not yet recruiting
Not Applicable
A clinical study of traditional Chinese medicine combined with western medicine in treatment of primary IgA nephropathy (IgAN) in CKD stage 3ITMCTR2200006488Shanghai east hospital (East Hospital affiliated to Tongji University)